Why the study?
Does an invasive management strategy reduce cardiovascular death or MI in patients with stable coronary disease or chronic coronary syndrome compared to optimal medical therapy alone?
Does an invasive management strategy reduce cardiovascular death or MI in patients with stable coronary disease or chronic coronary syndrome compared to optimal medical therapy alone?
Previous trials in the bare metal stent era showed no superiority of invasive management over optimal medical therapy for reducing cardiovascular death or MI in stable coronary disease.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Elgendy et al. (2020) conducted a review in stable coronary disease or chronic coronary syndrome. invasive management strategy vs. optimal medical therapy (OMT) was evaluated on cardiovascular death or MI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More on Coronary artery diseaseMore from European Cardiology Review